This website is intended for healthcare professionals
Respiratory Handbook

The professional's guide to product selection

Combiprasal - Ipratropium bromide with salbutamol

TriOn Pharma

Description

Antimuscarinic bronchodilator with short-acting selective beta2 agonist.

• Adult and child over 12 years for bronchospasm in chronic obstructive pulmonary disease: by inhalation of nebulised solution, 0.5/2.5 mg, 3–4 times daily.

Indications

For the treatment of bronchospasm in COPD.

Preparations Available

Nebuliser liquid

Sizes Available

Nebuliser liquid
Combiprasal 0.5/2.5 mg, 2.5 ml, 60 units 

More on: Bronchodilators , Compound preparations